Rocky Mountain Cancer Centers-Boulder — Boulder, Colorado

Public research footprint of Rocky Mountain Cancer Centers-Boulder, compiled from the ClinicalTrials.gov public registry.

222

Registered studies

137

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Platinum-Resistant Ovarian Carcinoma · Stage IV Cutaneous Melanoma AJCC v6 and v7 · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma

Recently updated registry entries

NCT04739800 — Comparison of Standard of Care Treatment With a Triplet Combination of Targeted… (Active Not Recruiting)
NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)
NCT03907488 — Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Rocky Mountain Cancer Centers-Boulder?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.